Access to Innovative Cancer Treatments for Children and Young People in Belgium

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will gather real-world safety and efficacy information from pediatric cancer patients treated with off‑label or compassionate-use drugs approved for adults after 2007. Data collection uses the Ennov EDC system and involves recognized pediatric hemato-oncology centers that coordinate through national tumor boards. The study aims to map use across the country and inform best therapeutic options for relapsed cases. Participation requires MDT discussion and consent where required by national rules. No new experimental treatments are being tested within a traditional trial framework.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≤ 25 at the time of inclusion in the study
* Patient with a pediatric malignancy (solid tumor or leukemia), or other related condition
* Patient not currently enrolled on any other trial for ongoing therapeutic purposes
* Patient treated with compassionate use of experimental drugs or off-label administration use of anti-cancer medicines first approved in adults after 2007 in Europe
* Patient discussed in a Pediatric multidisciplinary tumor boards (MDTB) to validate the inclusion in the SACHA study
* Consent to participate by the patient or his/her legal representatives in the study if required by ta particular national jurisdiction

Exclusion Criteria:

* Patient receiving the drug within a clinical trial.
* Oral refusal to participate to the study, by the patient or his/her parents/legal representatives.

Where it's running

• University Hospital Leuven
  Leuven, Belgium Recruiting
• University Hospital Antwerp
  Antwerp, Belgium Not yet recruiting
• Hôpital Universitaire des Enfants Reine Fabiola (HUDERF)
  Brussels, Belgium Not yet recruiting
• Cliniques Universitaires Saint-Luc
  Brussels, Belgium Not yet recruiting
• University Hospital Gent
  Ghent, Belgium Not yet recruiting
• CHC Montlégia
  Liège, Belgium Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FaceSay: a computer program to help kids recognize facial expressions and improve social interactions

  A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.

  Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT07923370

• BCB-276 CAR T therapy for DIPG in children and young adults

  This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.

  Recruiting at 3 sites Phase 2 BrainChild Bio, Inc · Los Angeles, California and 5 other locations · NCT07680439

• CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes

  This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.

  Recruiting Resonance, Inc. · Yerevan and 5 other locations · NCT07632014

• Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children

  This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.

  Recruiting TC Erciyes University · Kayseri · NCT07537062

• Laser thermal therapy for young people with low-grade glioma

  This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07506239

• Thyroid cancer risk and follow-up after childhood radiotherapy

  This project will test whether earlier and regular ultrasound plus genetic testing can detect thyroid nodules and cancers sooner in children treated with radiotherapy.

  Recruiting at 2 sites IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna and 1 other locations · NCT07473518

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.